eprintid: 443
rev_number: 11
eprint_status: archive
userid: 30
dir: disk0/00/00/04/43
datestamp: 2021-06-22 14:57:56
lastmod: 2021-06-22 15:00:18
status_changed: 2021-06-22 14:57:56
type: thesis
metadata_visibility: show
creators_name: Cullen, Karl
corp_creators: Supervisor: Kathy Clarke
title: The Impact of Blockchain Technology on Clinical Trial Data Integrity
ispublished: submitted
subjects: RS
divisions: MScPBT
full_text_status: public
keywords: Blockchain Technology; Clinical Trial Data
abstract: In this study it was shown how a new and emerging technology known as Blockchain, a data management platform, possesses the potential to address some of the predominant issues pertaining to clinical data integrity within clinical trial research studies. However, many obstacles and challenges persist with its implementation and these must be addressed, understood and solved before the technology can be utilized to manage clinical data. The main research objective of this study was to examine how Blockchain could be suited to address the concerns relating to clinical data integrity and to address the perceptions of participants involved with clinical data management to the technology and its potential application within clinical trials. Through an exploratory quantitative and qualitative mixed methods approach aligned with a pragmatist research philosophy, primary data was collected from participants who were purposively selected from a homogenous sampling pool that consisted of those with backgrounds in clinical data management. Primary data produced from this study highlighted the correlation of data issues that contribute towards the lack of integrity of clinical data with those found in secondary research. It was also found that the perception of Blockchain was generally positive and favorable towards its adoption within clinical trials. However, there was a degree of uncertainty surrounding the security of data within Blockchain. Various challenges were identified, primarily, the complexity of the technology and challenges related to compliancy with data protection laws. The conclusive determination of Blockchain’s suitability to address clinical data concerns, however, remains unanswered and further research is needed to test the application of Blockchain in real-world clinical trial environments. Further research and studies are also necessary to address the many challenges that face Blockchains implementation with clinical data management.
date: 2020
date_type: completed
institution: Griffith College
department: Innopharma
thesis_type: masters
referencetext: Albanese, G. et al. (2020) ‘Dynamic consent management for clinical trials via private blockchain technology', Journal of Ambient Intelligence and Humanized Computing. doi: 10.1007/s12652 020-01761-1.

Alshamsi, A. and Andras, P. (2019) ‘User Perception of Bitcoin Usability and Security across Novice Users'.

Bashir, I. (2017) Mastering Blockchain: Deeper insights into decentralization, cryptography, Bitcoin, and popular Blockchain frameworks. 2nd edn. Birmingham, UK: Packt Publishing.

Benchoufi, M., Porcher, R. and Ravaud, P. (2018) ‘Blockchain protocols in clinical trials: Transparency and traceability of consent', F1000Research, 6. doi: 10.12688/f1000research.10531.5.

Benchoufi, M. and Ravaud, P. (2017) ‘Blockchain Technology for Improving Clinical Research Quality', Trials, 18(1), p. 335. doi: 10.1186/s13063-017-2035-z.

Braun, V. and Clarke, V. (2006) ‘Using thematic analysis in psychology', Qualitative Research in Psychology. Routledge, 3(2), pp. 77-101. doi: 10.1191/1478088706qp063oa.

Burrell, G. and Morgan, G. (1979) Sociological Paradigms and Organisational Analysis: Elements of the Sociology of Corporate Life. 1 edition. London: Pearson Education.

Carlisle, J. B. (2017) ‘Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals', Anaesthesia, 72(8), pp. 944-952. doi: 10.1111/anae.13938.

ClinicalTrials.Gov (2020) Trends, Charts, and Maps - ClinicalTrials.gov, ClinicalTrials. Available at: https://clinicaltrials.gov/ct2/resources/trends (Accessed: 16 May 2020).

Crosby, M. (2016) ‘BlockChain Technology: Beyond Bitcoin', Applied Innovation Review, (2), p. 16.

European Parliament (2020) Blockchain and the General Data Protection Regulation. Brussels: European Parliamentary Research Service, pp. 1-101. Available at: https://www.europarl.europa.eu/RegData/etudes/STUD/2019/634445/EPRS_STU%282019%29 634445_EN.pdf (Accessed: 12 July 2020).

FDA (2013) ‘Guidance for Industry Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring'. Available at: https://www.fda.gov/media/116754/download.

FDA (2016) ‘Data Integrity and Compliance With CGMP Guidance for Industry'. Food and Drug Administration. Available at: https://www.fda.gov/files/drugs/published/Data-Integrity-and Compliance-With-Current-Good-Manufacturing-Practice-Guidance-for-Industry.pdf (Accessed: 21 June 2020).

Friar, H. S. and Kirsh, D. (2019) Why data integrity is important for the success of clinical trials, MassDevice. Available at: https://www.massdevice.com/why-data-integrity-is-important-forthe-success-of-clinical-trials/ (Accessed: 24 June 2020). George, S. L. (2016) ‘Research misconduct and data fraud in clinical trials: prevalence and causal factors', International Journal of Clinical Oncology, 21(1), pp. 15-21. doi: 10.1007/s10147-015 0887-3.

George, S. L. and Buyse, M. (2015) ‘Data fraud in clinical trials', Clinical investigation, 5(2), pp. 161-173. doi: 10.4155/cli.14.116.

Gupta, A. (2013) ‘Fraud and misconduct in clinical research: A concern', Perspectives in clinical research. (Perspectives in Clinical Research), 4(2). doi: 10.4103/2229-3485.111800.

Hirano, T. et al. (2020) ‘Data validation and verification using blockchain in a clinical trial for breast cancer', p. 30.

Hölbl, M. et al. (2018) ‘A Systematic Review of the Use of Blockchain in Healthcare', Symmetry, 10, p. 470. doi: 10.3390/sym10100470.

Holdowsky, J., Lele, N. and Lougheed, G. (2018) Many paths lead to blockchain adoption, and no two are alike, Deloitte Insights. Available at: https://www2.deloitte.com/us/en/insights/topics/understanding-blockchain-potential/globalblockchain-survey/2019-adoption-by-industry.html (Accessed: 8 July 2020).

Hume, S. et al. (2017) ‘Visualizing and Validating Metadata Traceability within the CDISC Standards', AMIA Summits on Translational Science Proceedings, 2017, pp. 158-165.

ICH (2018) ‘E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1) Guidance for Industry'. International Council for Harmonization. Available at: https://www.fda.gov/media/93884/download (Accessed: 13 May 2020).

Khin, N. A. et al. (2020) ‘Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop', Clinical Pharmacology and Therapeutics. doi: 10.1002/cpt.1794.

Krishnankutty, B. et al. (2012) ‘Data management in clinical research: An overview', Indian Journal of Pharmacology, 44(2), pp. 168-172. doi: 10.4103/0253-7613.93842.

Kuo, T.-T., Kim, H.-E. and Ohno-Machado, L. (2017) ‘Blockchain distributed ledger technologies for biomedical and health care applications', Journal of the American Medical Informatics Association. Oxford Academic, 24(6), pp. 1211-1220. doi: 10.1093/jamia/ocx068.

Lin, I.-C. and Liao, T.-C. (2017) ‘A survey of blockchain security issues and challenges', International Journal of Network Security, 19(5), pp. 653-659. doi: 10.6633/IJNS.201709.19(5).01.

Mackey, T. K. et al. (2019) ‘“Fit-for-purpose?” - challenges and opportunities for applications of blockchain technology in the future of healthcare', BMC Medicine. (Beyong Big Data to new Biomedical and Health Data Science), 17, pp. 1-17. doi: 10.1186/s12916-019-1296-7.

Mann, S. P. et al. (2020) ‘Blockchain, consent and prosent for medical research', Journal of Medical Ethics. Institute of Medical Ethics, pp. 1-7. doi: 10.1136/medethics-2019-105963.

MarketsandMarkets (2020) Blockchain Market Size, Growth, Trends and Forecast to 2025 | MarketsandMarkets, Blockchain Market by Component (Platform and Services), Provider (Application, Middleware, and Infrastructure), Type (Private, Public, and Hybrid), Organization Size, Application Area (BFSI, Government, IT & Telecom), and Region - Global Forecast to 2025. Available at: https://www.marketsandmarkets.com/Market-Reports/blockchain-technologymarket-90100890.html (Accessed: 12 August 2020).

Maslove, D. M. et al. (2018) ‘Using Blockchain Technology to Manage Clinical Trials Data: A Proof-of-Concept Study', JMIR Medical Informatics, 6(4). doi: 10.2196/11949.

MRC (2014) ‘MRC Policy and Procedure for Investigating Allegations of Research Misconduct'. Medical Research Council. Available at: https://mrc.ukri.org/documents/pdf/mrc-policy-onresearch-misconduct/ (Accessed: 29 June 2020).

Nakamoto, S. (2009) ‘Bitcoin: A Peer-to-Peer Electronic Cash System', p. 9.

Pocock, S. J. (2013) Clinical Trials: A Practical Approach. 1st edn. Wiley. Available at: https://www.amazon.co.uk/Clinical-Trials-Practical-Approach-Publications/dp/0471901555 (Accessed: 2 July 2020).

Sarmah, S. (2018) ‘Understanding Blockchain Technology', Computing Science and Engineering, 8(2), pp. 23-29. doi: 10.5923/j.computer.20180802.02.

Saunders, M. N. K., Lewis, P. and Thornhill, A. (2015) Research Methods for Business Students. 7 edition. New York: Pearson.

Scarso Borioli, G. and Couturier, J. (2018) ‘How blockchain technology can improve the outcomes of clinical trials', British Journal of Healthcare Management, 24, pp. 156-162. doi: 10.12968/bjhc.2018.24.3.156.

Segen's Medical Dictionary (2012) data integrity, TheFreeDictionary.com. Available at: https://medical-dictionary.thefreedictionary.com/data+integrity (Accessed: 24 June 2020).

Seife, C. (2015) ‘Research Misconduct Identified by the US Food and Drug Administration: Out of Sight, Out of Mind, Out of the Peer-Reviewed Literature', JAMA Internal Medicine, 175(4), p. 567. doi: 10.1001/jamainternmed.2014.7774.

Sertkaya, A. et al. (2016) ‘Key cost drivers of pharmaceutical clinical trials in the United States', Clinical Trials, 13(2), pp. 117-126. doi: 10.1177/1740774515625964.

Shamley, D. and Wright, B. (eds) (2017) A comprehensive and practical guide to clinical trials. London, United Kingdom; San Deigo, CA, United States: Elsevier/AP, Academic Press, an imprint of Elsevier.

Triall (2019) ‘A brief introduction to clinical trials', Insights by Triall.io, 3 July. Available at: https://insights.triall.io/a-brief-introduction-to-clinical-trials-medical-research-andpharmaceutical-innovation/ (Accessed: 2 July 2020).

Vujicic, D., Jagodic, D. and Ranđić, S. (2018) ‘Blockchain technology, bitcoin, and Ethereum: A brief overview', in. Cacak, Serbia: Faculty of Technical Sciences University of Kragujevac, pp. 1-6. doi: 10.1109/INFOTEH.2018.8345547.

WHO (2018) Clinical trials, Clinical Trials. Available at: https://www.who.int/westernpacific/health-topics/clinical-trials (Accessed: 26 June 2020).

Wong, C. H., Siah, K. W. and Lo, A. W. (2019) ‘Estimation of clinical trial success rates and related parameters', Biostatistics, 20(2), pp. 273-286. doi: 10.1093/biostatistics/kxx069. Wong, D. R., Bhattacharya, S. and Butte, A. J. (2019) ‘Prototype of running clinical trials in an untrustworthy environment using blockchain', Nature Communications. Nature Publishing Group, 10(1), pp. 1-8. doi: 10.1038/s41467-019-08874-y.

Zheng, Z. et al. (2017) ‘An Overview of Blockchain Technology: Architecture, Consensus, and Future Trends', in 2017 IEEE International Congress on Big Data (BigData Congress). 2017 IEEE International Congress on Big Data (BigData Congress), IEEE Computer Society, pp. 557- 564. doi: 10.1109/BigDataCongress.2017.85.

Zheng, Z. et al. (2018) ‘Blockchain challenges and opportunities: A survey', International Journal of Web and Grid Services, 14, p. 352. doi: 10.1504/IJWGS.2018.095647. Appendices
citation:   Cullen, Karl  (2020) The Impact of Blockchain Technology on Clinical Trial Data Integrity.  Masters thesis, Griffith College.   
document_url: http://go.griffith.ie/443/1/3939_Karl_Cullen_Karl_Cullen_Thesis_7332_1873932357.pdf
document_url: http://go.griffith.ie/443/2/bibliography.txt